Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...
The following is a summary of “Patient Characteristics, Management and Long-term Outcomes of Patients with Cardiogenic Shock ...
Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.
The current approach, which initiates medications and escalates to mechanical circulatory support, has not resulted in a ...
Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...
Cardiogenic shock, often caused by heart failure, is marked by dangerously low blood pressure that compromises blood flow to vital organs, leading to high morbidity and mortality rates.
Are you searching for effective medications to treat 'Cardiogenic Shock'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...
Inflammation can trigger heart attacks in people with coronary artery disease. It can also exacerbate heart failure symptoms ...
Dr. Alexandre Mebazaa is Professor of Medicine at Université Paris Cité (France), Chair of Department of Anesthesia & Critical Care and an expert in heart failure and cardiogenic shock. He is part of ...
Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...